Apellis Pharmaceuticals’ Syfovre, a treatment for geographic atrophy, has received FDA approval.
FDA approves first and only treatment for leading cause of blindness
Apellis Pharmaceuticals’ Syfovre, a treatment for geographic atrophy, has received FDA approval.